GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dingdang Health Technology Group Ltd (HKSE:09886) » Definitions » ROC %

Dingdang Health Technology Group (HKSE:09886) ROC % : -23.36% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Dingdang Health Technology Group ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Dingdang Health Technology Group's annualized return on capital (ROC %) for the quarter that ended in Dec. 2024 was -23.36%.

As of today (2025-04-07), Dingdang Health Technology Group's WACC % is 9.09%. Dingdang Health Technology Group's ROC % is -22.81% (calculated using TTM income statement data). Dingdang Health Technology Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Dingdang Health Technology Group ROC % Historical Data

The historical data trend for Dingdang Health Technology Group's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dingdang Health Technology Group ROC % Chart

Dingdang Health Technology Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC %
Get a 7-Day Free Trial -24.65 -78.00 -29.27 -24.83 -23.04

Dingdang Health Technology Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -19.48 -28.09 -26.76 -22.74 -23.36

Dingdang Health Technology Group ROC % Calculation

Dingdang Health Technology Group's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2024 is calculated as:

ROC % (A: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2023 ) + Invested Capital (A: Dec. 2024 ))/ count )
=-214.582 * ( 1 - -2.67% )/( (1093.094 + 819.201)/ 2 )
=-220.3113394/956.1475
=-23.04 %

where

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3352.179 - 805.098 - ( 1453.987 - max(0, 998.121 - 2594.454+1453.987))
=1093.094

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2810.834 - 691.258 - ( 1300.375 - max(0, 888.325 - 2350.601+1300.375))
=819.201

Dingdang Health Technology Group's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-209.5 * ( 1 - -1.3% )/( (998.02 + 819.201)/ 2 )
=-212.2235/908.6105
=-23.36 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3219.288 - 793.499 - ( 1427.769 - max(0, 985.573 - 2506.199+1427.769))
=998.02

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2810.834 - 691.258 - ( 1300.375 - max(0, 888.325 - 2350.601+1300.375))
=819.201

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dingdang Health Technology Group  (HKSE:09886) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Dingdang Health Technology Group's WACC % is 9.09%. Dingdang Health Technology Group's ROC % is -22.81% (calculated using TTM income statement data). Dingdang Health Technology Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Dingdang Health Technology Group ROC % Related Terms

Thank you for viewing the detailed overview of Dingdang Health Technology Group's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dingdang Health Technology Group Business Description

Traded in Other Exchanges
N/A
Address
Dengshikou Street, Building 1, Yard 50, Dongcheng District, Beijing, CHN
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Executives
Shen Zhen Zhao Yin Dian Xin Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shen Zhen Zhao Yin Dian Xin Xin Qu Shi Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Guang Zhou Shi Zhao Xin Wu Ji Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Tian Jin Shan Hai Yi Hao Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Yang Xiao
Yang Yibin
Yang Wenlong
Chuang Ji Tou Zi You Xian Gong Si
Zhi Sheng Qi Ye You Xian Gong Si
Jin Fa You Xian Gong Si
Jian Fa You Xian Gong Si
Zhi Ying Ji Tuan You Xian Gong Si
Jian Xing You Xian Gong Si
Xing Xin You Xian Gong Si

Dingdang Health Technology Group Headlines

No Headlines